PTK2 and thyroid gland carcinoma: This is different to the data obtained with thyroid cancer cells, where the PTK2 mRNA in FTC-133 thyroid cancer cells was differentially expressed in the TEXUS samples, but the FAK1 protein content was significantly reduced in RPM samples [14].